170242-34-9Relevant articles and documents
The combination of hydroformylation and biocatalysis for the large-scale synthesis of (S)-allysine ethylene acetal
Cobley, Christopher J.,Lloyd, Michael C.,Simmonds, Shaun,Hanson, Christopher H.,Peng, Wei Jun
experimental part, p. 284 - 290 (2011/10/02)
The compound, (S)-2-amino-5-[1,3]dioxolan-2-yl-pentanoic acid [(S)-allysine ethylene acetal], is a key intermediate in a number of angiotension-I converting enzyme (ACE) and neutral endopeptidase (NEP) inhibitors currently in clinical trials. Through a co
Method for producing L-Allysine acetal
-
, (2008/06/13)
A method for producing L-allysine acetal represented by general formula (II), comprising reacting D,L-allysinamide acetal represented by general formula (I) with cells of microorganism or treated cell product having an activity of stereoselectively hydrolyzing L-allysinamide acetal, wherein R1and R2, which may be the same or different, each independently represent a lower alkyl group, or R1and R2are combined to form an alkylene group represented by [CH2]n, and n is 2 to 3. D,L-allysinamide acetal represented by general formula (I) is also in the scope of the invention. According to the present invention, L-allysine acetal useful as a raw material for medicine can be produced in a smaller number of steps at low costs.